Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Working Capital Changes: 2012-2024

Historic Other Working Capital Changes for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $10.7 million.

  • Amphastar Pharmaceuticals' Other Working Capital Changes fell 25.99% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 2.05%. This contributed to the annual value of $10.7 million for FY2024, which is 1975222.28% up from last year.
  • Amphastar Pharmaceuticals' Other Working Capital Changes amounted to $10.7 million in FY2024, which was up 1,975,222.28% from $543 recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Other Working Capital Changes registered a high of $10.7 million during FY2024, and its lowest value of $543 during FY2023.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Other Working Capital Changes value was $5,614 (recorded in 2022), while the average stood at $3.6 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 93.67% in 2021, then skyrocketed by 1,975,222.28% in 2024.
  • Amphastar Pharmaceuticals' Other Working Capital Changes (Yearly) stood at $1.1 million in 2020, then tumbled by 93.67% to $70,451 in 2021, then slumped by 92.03% to $5,614 in 2022, then plummeted by 90.33% to $543 in 2023, then surged by 1,975,222.28% to $10.7 million in 2024.